▁The 3.1640625
▁article 7.5390625
▁" 4.015625
Chr 8.1328125
onic 1.0263671875
▁In 4.12109375
fl 0.30029296875
amm 0.33447265625
ation 0.010101318359375
▁in 2.396484375
▁End 5.921875
- 2.4296875
Stage 0.295166015625
▁Ren 0.27734375
al 0.00014150142669677734
▁D 0.093505859375
ise 0.0032939910888671875
ase 0.006214141845703125
▁and 3.283203125
▁D 3.103515625
ial 0.00946044921875
ysis 0.00955963134765625
" 0.87255859375
▁provides 3.466796875
▁compreh 4.76171875
ensive 0.00362396240234375
▁insight 3.6875
▁into 0.414794921875
▁the 0.31982421875
▁leading 7.2578125
▁causes 0.8203125
▁of 0.3486328125
▁chron 0.56201171875
ic 0.0006208419799804688
▁infl 0.039306640625
amm 0.025543212890625
ation 0.001346588134765625
▁in 0.304931640625
▁individuals 4.30078125
▁suffering 2.587890625
▁from 0.0207366943359375
▁end 0.41748046875
- 0.029083251953125
stage 0.0027370452880859375
▁ren 0.035491943359375
al 0.00012314319610595703
▁failure 4.6328125
. 1.1455078125
▁As 4.703125
▁a 1.822265625
▁high 6.609375
- 0.55029296875
school 7.296875
▁student 0.384765625
, 0.6484375
▁I 0.4765625
▁found 1.580078125
▁this 0.8212890625
▁article 0.2218017578125
▁to 0.55029296875
▁be 0.016204833984375
▁quite 2.96875
▁en 3.294921875
light 0.0150604248046875
ening 0.0010480880737304688
▁and 1.5185546875
▁inform 1.140625
ative 0.0227203369140625
. 0.548828125
<0x0A> 1.6103515625
Acc 3.59375
ording 0.00104522705078125
▁to 0.00164031982421875
▁the 0.156005859375
▁article 0.226806640625
, 0.01502227783203125
▁chron 1.091796875
ic 0.000186920166015625
▁infl 0.031982421875
amm 0.01137542724609375
ation 0.0008139610290527344
▁is 0.3583984375
▁a 0.434814453125
▁common 1.31640625
▁occurrence 1.4892578125
▁in 0.1810302734375
▁patients 1.86328125
▁with 0.33740234375
▁end 0.11553955078125
- 0.0031070709228515625
stage 0.0008831024169921875
▁ren 0.01491546630859375
al 6.020069122314453e-05
▁disease 0.0965576171875
▁( 0.87646484375
ES 0.004001617431640625
R 0.0007643699645996094
D 0.00013124942779541016
) 0.53076171875
▁and 0.2117919921875
▁those 2.4140625
▁under 1.216796875
going 0.002109527587890625
▁d 0.12310791015625
ial 9.775161743164062e-06
ysis 0.00040459632873535156
▁treatment 1.5693359375
. 0.0999755859375
▁The 0.9755859375
▁leading 2.03515625
▁causes 0.25439453125
▁of 0.04058837890625
▁chron 0.203125
ic 5.5909156799316406e-05
▁infl 0.0009393692016601562
amm 0.00202178955078125
ation 0.00012159347534179688
▁in 0.11505126953125
▁these 0.794921875
▁individuals 0.412109375
▁include 0.578125
▁repeated 8.1875
▁d 2.998046875
ial 0.00044655799865722656
ysis 0.01165008544921875
- 2.8359375
related 0.390380859375
▁in 2.287109375
fe 0.042694091796875
ctions 0.00010466575622558594
, 0.08856201171875
▁v 4.7265625
asc 0.0026092529296875
ular 4.0531158447265625e-05
▁access 0.20068359375
▁d 2.953125
ys 0.027435302734375
function 0.01555633544921875
, 0.056915283203125
▁and 0.6025390625
▁the 3.181640625
▁presence 1.3095703125
▁of 0.0006666183471679688
▁middle 12.03125
▁mole 2.890625
cules 0.360595703125
. 0.9091796875
▁Under 5.33984375
standing 0.015869140625
▁these 1.7607421875
▁causes 0.310302734375
▁is 0.8740234375
▁cru 0.904296875
cial 0.000110626220703125
▁to 3.001953125
▁impro 2.501953125
ving 0.0003173351287841797
▁the 0.68505859375
▁clin 5.09765625
ical 0.0013685226440429688
▁out 0.525390625
comes 0.0011358261108398438
▁of 0.46630859375
▁patients 0.646484375
. 4.97265625
<0x0A> 0.06744384765625
The 0.78564453125
▁impact 6.046875
▁of 0.03424072265625
▁chron 0.572265625
ic 7.426738739013672e-05
▁infl 0.00513458251953125
amm 0.0024967193603515625
ation 8.58306884765625e-05
▁on 0.3583984375
▁clin 4.03125
ical 0.0008802413940429688
▁out 0.01392364501953125
comes 5.352497100830078e-05
▁cannot 3.693359375
▁be 0.00017976760864257812
▁under 1.501953125
st 0.359375
ated 0.0001519918441772461
. 0.073974609375
▁It 1.654296875
▁is 1.2890625
▁associated 1.5615234375
▁with 0.00039958953857421875
▁significant 4.21484375
▁mor 0.288818359375
bid 0.00018513202667236328
ity 0.0217742919921875
▁and 0.1923828125
▁mort 0.0340576171875
ality 0.00012063980102539062
▁in 1.4423828125
▁E 1.716796875
SR 0.00015592575073242188
D 1.6689300537109375e-05
▁patients 0.440185546875
. 0.90185546875
▁For 4.00390625
▁instance 1.0888671875
, 0.0001608133316040039
▁chron 1.4052734375
ic 0.0012922286987304688
▁infl 0.034820556640625
amm 0.0179901123046875
ation 7.355213165283203e-05
▁can 1.984375
▁contribute 3.30078125
▁to 0.004268646240234375
▁the 0.5810546875
▁development 0.15380859375
▁of 0.00946044921875
▁card 0.8330078125
i 0.00691986083984375
ov 0.0003962516784667969
asc 5.269050598144531e-05
ular 5.0067901611328125e-06
▁disease 0.2841796875
, 0.256591796875
▁mal 4.01171875
nut 0.0034122467041015625
r 4.935264587402344e-05
ition 7.390975952148438e-05
, 0.00931549072265625
▁and 0.26416015625
▁imp 3.994140625
a 0.0267791748046875
ired 7.748603820800781e-06
▁imm 1.4951171875
une 0.30078125
▁function 0.313720703125
. 0.32421875
▁Moreover 2.966796875
, 9.930133819580078e-05
▁it 0.77001953125
▁can 0.395263671875
▁also 1.5830078125
▁lead 0.92822265625
▁to 6.771087646484375e-05
▁poor 3.66015625
▁quality 1.611328125
▁of 0.00493621826171875
▁life 0.0002841949462890625
▁and 0.45751953125
▁increased 1.16796875
▁hospital 1.69140625
ization 0.400390625
▁rates 0.1348876953125
. 0.07080078125
<0x0A> 0.19775390625
One 3.630859375
▁significant 5.03125
▁aspect 2.8203125
▁discussed 5.296875
▁in 0.00839996337890625
▁the 0.0112762451171875
▁article 0.002086639404296875
▁is 0.08935546875
▁the 0.07977294921875
▁role 1.0693359375
▁of 0.01282501220703125
▁middle 1.4423828125
▁mole 0.005786895751953125
cules 0.009185791015625
▁in 0.07281494140625
▁the 1.302734375
▁development 0.1788330078125
▁of 0.0089263916015625
▁path 10.4609375
ology 2.890625
. 1.2529296875
▁These 1.568359375
▁middle 4.16796875
▁mole 0.01131439208984375
cules 0.0020694732666015625
, 1.3271484375
▁such 1.28125
▁as 0.00010800361633300781
▁beta 5.82421875
- 0.2196044921875
2 0.294677734375
▁micro 1.228515625
glob 0.0033054351806640625
ul 0.000980377197265625
in 0.06317138671875
, 0.73193359375
▁cy 4.8515625
tok 0.0281219482421875
ines 0.00812530517578125
, 0.0122528076171875
▁and 0.06982421875
▁advanced 3.412109375
▁g 0.052520751953125
ly 0.00010526180267333984
cation 0.00927734375
▁end 0.0089874267578125
- 1.9404296875
products 0.007579803466796875
, 0.4775390625
▁can 1.5439453125
▁accum 2.8984375
ulate 0.00010454654693603516
▁in 0.2890625
▁E 3.330078125
SR 9.894371032714844e-05
D 2.288818359375e-05
▁patients 0.08056640625
▁due 1.369140625
▁to 0.00013911724090576172
▁imp 1.939453125
a 0.00957489013671875
ired 1.3113021850585938e-06
▁ren 1.0087890625
al 5.733966827392578e-05
▁function 0.64306640625
▁and 1.833984375
▁in 4.67578125
efficient 2.89453125
▁d 2.796875
ial 0.0005178451538085938
ysis 0.03173828125
▁clear 3.013671875
ance 0.01151275634765625
. 0.02587890625
▁This 0.982421875
▁accum 0.343017578125
ulation 0.000194549560546875
▁cont 4.3203125
ributes 5.9604644775390625e-06
▁to 0.0347900390625
▁chron 1.0419921875
ic 9.298324584960938e-05
▁infl 0.005802154541015625
amm 0.01074981689453125
ation 4.2438507080078125e-05
▁and 0.462890625
▁subsequent 3.33984375
▁t 2.560546875
issue 0.0002046823501586914
▁damage 0.215576171875
. 0.24658203125
▁Under 4.72265625
standing 0.0016984939575195312
▁the 0.1224365234375
▁role 0.484619140625
▁of 0.004650115966796875
▁middle 0.63720703125
▁mole 0.0005698204040527344
cules 0.00196075439453125
▁is 1.41796875
▁cru 0.46875
cial 1.7523765563964844e-05
▁in 1.296875
▁gu 7.13671875
iding 6.35385513305664e-05
▁future 2.80859375
▁research 0.80419921875
▁and 0.1890869140625
▁th 3.029296875
era 0.00011861324310302734
pe 1.239776611328125e-05
ut 2.372264862060547e-05
ic 0.007549285888671875
▁inter 1.1103515625
vent 0.00875091552734375
ions 7.987022399902344e-06
. 0.72705078125
<0x0A> 0.00647735595703125
F 3.40234375
ort 4.69140625
un 0.000431060791015625
ately 0.00016069412231445312
, 0.00026869773864746094
▁there 0.607421875
▁have 4.71484375
▁been 0.002349853515625
▁recent 1.9443359375
▁break 3.94140625
through 6.520748138427734e-05
s 0.0012292861938476562
▁and 5.4921875
▁on 4.60546875
going 0.00614166259765625
▁research 0.35595703125
▁in 1.17578125
▁d 4.8515625
ial 0.0009088516235351562
ysis 0.013641357421875
▁that 3.181640625
▁aim 2.45703125
▁to 0.00832366943359375
▁stabil 10.234375
ize 0.00335693359375
▁the 1.294921875
▁condition 5.05078125
. 1.7294921875
▁The 2.0
▁article 1.13671875
▁mentions 2.1875
▁the 1.015625
▁util 5.52734375
ization 0.001712799072265625
▁of 0.0013017654418945312
▁hem 3.822265625
odia 0.71728515625
fil 0.0201568603515625
tr 0.0028514862060546875
ation 0.0005846023559570312
▁and 1.8583984375
▁online 4.76953125
- 4.86328125
liver 10.0390625
▁ad 7.3046875
s 0.04266357421875
or 0.0159912109375
ption 0.07281494140625
▁as 1.6083984375
▁potential 1.1796875
▁treatment 2.794921875
▁modal 3.89453125
ities 7.009506225585938e-05
. 1.0458984375
▁These 0.77783203125
▁innov 2.46875
ative 0.54931640625
▁approaches 0.982421875
▁have 1.23828125
▁shown 0.70263671875
▁promise 1.5009765625
▁in 0.017181396484375
▁reducing 0.58837890625
▁middle 1.6064453125
▁mole 0.0543212890625
c 0.66943359375
ule 2.5391578674316406e-05
▁concentr 2.84375
ations 6.389617919921875e-05
▁and 0.363525390625
▁impro 0.8974609375
ving 1.7762184143066406e-05
▁patient 2.16015625
▁out 0.043701171875
comes 1.4543533325195312e-05
. 0.027618408203125
▁Additionally 4.0
, 0.00012552738189697266
▁the 0.8203125
▁use 1.1982421875
▁of 0.00018596649169921875
▁bio 5.00390625
compatible 1.4521484375
▁d 2.24609375
ial 0.00031495094299316406
ysis 0.7109375
▁memb 0.1895751953125
ran 0.0202484130859375
es 4.5180320739746094e-05
▁has 1.7685546875
▁gained 5.2734375
▁attention 1.3173828125
▁as 0.6904296875
▁a 0.1708984375
▁means 2.44921875
▁to 1.5244140625
▁reduce 1.0205078125
▁infl 1.234375
amm 0.2257080078125
ation 0.0009064674377441406
▁and 0.469970703125
▁enh 3.54296875
ance 2.8014183044433594e-05
▁d 1.5341796875
ial 0.00011837482452392578
ysis 0.0269622802734375
▁efficiency 1.0224609375
. 0.01390838623046875
<0x0A> 0.09027099609375
In 0.9384765625
▁conclusion 0.1864013671875
, 0.00011444091796875
▁the 1.421875
▁article 0.043365478515625
▁sh 6.37109375
eds 0.00984954833984375
▁light 0.033355712890625
▁on 0.00035858154296875
▁the 0.069580078125
▁leading 1.5673828125
▁causes 0.006526947021484375
▁of 0.03961181640625
▁chron 0.0065765380859375
ic 1.800060272216797e-05
▁infl 0.00040531158447265625
amm 0.0007319450378417969
ation 3.552436828613281e-05
▁in 0.01239013671875
▁individuals 0.88720703125
▁with 0.5234375
▁end 0.9814453125
- 0.000537872314453125
stage 0.00025343894958496094
▁ren 0.00450897216796875
al 4.0531158447265625e-06
▁disease 0.2059326171875
▁and 0.188232421875
▁under 2.40625
going 0.00047469139099121094
▁d 0.0041046142578125
ial 2.86102294921875e-06
ysis 0.00020051002502441406
. 1.6611328125
▁It 1.37890625
▁emphas 0.8837890625
izes 0.0004608631134033203
▁the 0.015655517578125
▁det 6.171875
r 0.000804901123046875
iment 9.5367431640625e-07
al 4.4465065002441406e-05
▁impact 0.513671875
▁of 0.0726318359375
▁chron 0.24755859375
ic 2.4318695068359375e-05
▁infl 0.0003936290740966797
amm 0.00045037269592285156
ation 2.1576881408691406e-05
▁on 0.06988525390625
▁clin 0.2335205078125
ical 0.00010073184967041016
▁out 0.0004968643188476562
comes 2.9802322387695312e-06
▁and 0.146240234375
▁the 1.5751953125
▁role 2.865234375
▁of 0.0092620849609375
▁middle 0.0701904296875
▁mole 0.0011186599731445312
cules 0.01383209228515625
▁in 0.0272979736328125
▁the 1.109375
▁development 0.096923828125
▁of 0.003170013427734375
▁path 0.11590576171875
ology 0.01003265380859375
. 0.00754547119140625
▁Moreover 2.255859375
, 0.00010216236114501953
▁it 0.299072265625
▁presents 4.94921875
▁the 2.83984375
▁latest 0.86474609375
▁break 1.4072265625
through 2.384185791015625e-05
s 0.0014753341674804688
▁and 0.238037109375
▁on 0.216064453125
going 9.143352508544922e-05
▁research 0.00408935546875
▁in 0.4140625
▁d 0.312744140625
ial 1.9550323486328125e-05
ysis 0.00025916099548339844
▁that 0.66796875
▁aim 0.1888427734375
▁to 0.0010251998901367188
▁stabil 0.432861328125
ize 0.00044226646423339844
▁the 0.07659912109375
▁condition 0.01654052734375
. 0.755859375
▁As 1.3857421875
▁a 0.0584716796875
▁high 0.44189453125
- 0.06964111328125
school 0.0009341239929199219
▁student 0.0035800933837890625
, 0.217041015625
▁I 0.1041259765625
▁am 2.755859375
▁excited 3.3671875
▁to 0.1939697265625
▁see 1.896484375
▁adv 5.42578125
anc 0.0831298828125
ements 7.987022399902344e-06
▁in 0.0523681640625
▁the 1.341796875
▁field 0.08734130859375
▁of 0.4521484375
▁d 0.3779296875
ial 7.3909759521484375e-06
ysis 0.00017714500427246094
▁that 2.10546875
▁can 1.046875
▁potentially 2.060546875
▁improve 0.191162109375
▁the 0.2158203125
▁lives 0.5498046875
▁of 0.0031833648681640625
▁those 1.8681640625
▁affected 2.140625
▁by 0.034271240234375
▁end 0.94677734375
- 0.00030517578125
stage 0.0002892017364501953
▁ren 0.004730224609375
al 8.702278137207031e-06
▁failure 2.251953125
. 0.08599853515625
▁It 6.59375
▁is 0.098388671875
▁my 2.361328125
▁hope 0.1632080078125
▁that 0.0017290115356445312
▁further 2.794921875
▁research 0.096435546875
▁and 0.2056884765625
▁innov 0.572265625
ation 0.4970703125
▁will 0.990234375
▁lead 0.58984375
▁to 0.0013284683227539062
▁better 1.6015625
▁treatment 1.279296875
▁options 0.459228515625
▁and 0.2447509765625
▁en 4.66015625
hanced 0.00044226646423339844
▁quality 1.50390625
▁of 0.0010986328125
▁life 0.0023174285888671875
▁for 0.004367828369140625
▁E 2.64453125
SR 0.00016164779663085938
D 3.457069396972656e-05
▁patients 0.0096435546875
. 0.27587890625
